DK1296722T3 - Radioterapi - Google Patents
RadioterapiInfo
- Publication number
- DK1296722T3 DK1296722T3 DK01945519T DK01945519T DK1296722T3 DK 1296722 T3 DK1296722 T3 DK 1296722T3 DK 01945519 T DK01945519 T DK 01945519T DK 01945519 T DK01945519 T DK 01945519T DK 1296722 T3 DK1296722 T3 DK 1296722T3
- Authority
- DK
- Denmark
- Prior art keywords
- bone
- tumors
- human
- subject
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20003457A NO313180B1 (no) | 2000-07-04 | 2000-07-04 | Bensökende alfapartikkel emitterende radiofarmasöytika |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1296722T3 true DK1296722T3 (da) | 2006-02-13 |
Family
ID=19911348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01945519T DK1296722T3 (da) | 2000-07-04 | 2001-07-04 | Radioterapi |
Country Status (15)
Country | Link |
---|---|
US (2) | US7056275B2 (ja) |
EP (1) | EP1296722B1 (ja) |
JP (1) | JP5219325B2 (ja) |
KR (1) | KR100892002B1 (ja) |
AT (1) | ATE305313T1 (ja) |
AU (2) | AU2001267734B2 (ja) |
CA (1) | CA2413736C (ja) |
CZ (1) | CZ299087B6 (ja) |
DE (1) | DE60113683T2 (ja) |
DK (1) | DK1296722T3 (ja) |
EA (1) | EA004899B1 (ja) |
ES (1) | ES2250419T3 (ja) |
NO (1) | NO313180B1 (ja) |
PL (1) | PL206209B1 (ja) |
WO (1) | WO2002005859A2 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
CA2381123C (en) * | 2000-02-25 | 2011-10-04 | Dangshe Ma | Actinium-225 complexes and conjugates for radioimmunotherapy |
NO313180B1 (no) * | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
US6670456B2 (en) * | 2001-02-28 | 2003-12-30 | Dow Global Technologies Inc. | Actinium-225 complexes and conjugates for targeted radiotherapy |
ZA200507983B (en) * | 2003-04-15 | 2007-03-28 | Algetaas | Thorium-227 for use in radiotherapy of soft tissue disease |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
PL1735013T3 (pl) * | 2004-02-20 | 2012-07-31 | Algeta Asa | Cząstki hydroksyapatytu alfa- i beta-emitujące |
LU91085B1 (en) * | 2004-06-25 | 2005-12-27 | European Community | Radionuclides for medical use. |
EP1763372B1 (en) * | 2004-06-25 | 2016-11-30 | The European Union, represented by the European Commission | Radionuclides for medical use |
US7794691B2 (en) | 2004-06-25 | 2010-09-14 | The European Community, Represented By The European Commission | Radionuclides for medical use |
GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
US8709380B1 (en) * | 2006-02-07 | 2014-04-29 | Sirius Medicine, Llc | Targeting agents for enhancing radiation therapy |
US8557601B2 (en) | 2006-07-10 | 2013-10-15 | The Regents Of The University Of California | Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
FR2913970B1 (fr) * | 2007-03-19 | 2009-06-12 | Cogema | Production de thorium 228 a partir d'un sel de thorium naturel |
US20080249398A1 (en) * | 2007-04-09 | 2008-10-09 | Harder George Fred | Hybrid Source Containing Multi-Radionuclides for Use in Radiation Therapy |
WO2011025790A1 (en) | 2009-08-24 | 2011-03-03 | Lumiphore, Inc. | Macrocyclic hopo chelators |
JP2013515744A (ja) * | 2009-12-24 | 2013-05-09 | ルミフォア,インコーポレイテッド | 放射性医薬品錯体 |
US9202602B2 (en) | 2010-02-10 | 2015-12-01 | Uchicago Argonne, Llc | Production of isotopes using high power proton beams |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
GB201208309D0 (en) | 2012-05-11 | 2012-06-27 | Algeta As | Complexes |
US11453652B2 (en) | 2013-03-15 | 2022-09-27 | Lumiphore, Inc. | Di-macrocycles |
GB201314718D0 (en) * | 2013-08-16 | 2013-10-02 | Algeta As | Quantification method |
GB201600154D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
GB201600158D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Purification method |
GB201600161D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope purification method |
SG11201806548UA (en) | 2016-03-24 | 2018-08-30 | Bayer Pharma AG | Radio-pharmaceutical complexes |
CR20180581A (es) | 2016-06-10 | 2019-02-11 | Bayer Pharma AG | Complejos radio-farmacéuticos |
AU2018265386B2 (en) | 2017-05-11 | 2020-07-23 | Alpha Tau Medical Ltd. | Polymer coatings for brachytherapy devices |
JP2021519126A (ja) | 2018-04-02 | 2021-08-10 | アルファ タウ メディカル リミテッド | 放射性核種の管理された放出 |
FR3088769B1 (fr) * | 2018-11-15 | 2020-12-25 | Orano Med | Procede de preparation d'au moins un generateur a haute teneur en radium-228 |
US20220152228A1 (en) * | 2019-03-01 | 2022-05-19 | Washington University | Compositions and methods for radiotherapy using chelated radiotherapeutic agents and non-target tissue blockade |
WO2021013978A1 (en) | 2019-07-25 | 2021-01-28 | Bayer As | Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer |
RU2767567C1 (ru) * | 2020-10-27 | 2022-03-17 | Станислав Анатольевич Дороватовский | Комплексные соединения, содержащие в своем составе радионуклид 227Th, а также бисфосфонатный фрагмент, способы их получения, а также потенциальное применение в качестве действующего вещества в составе остеотропного радиофармацевтического лекарственного препарата |
US11857803B2 (en) | 2020-12-16 | 2024-01-02 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy with enhanced beta treatment |
KR102545315B1 (ko) | 2021-01-05 | 2023-06-20 | 한국과학기술원 | 의료용 방사성 동위원소의 생산 방법 및 시스템 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2329147A (en) * | 1938-05-07 | 1943-09-07 | Rare Chemicals Inc | Stabilized metal sol and method of preparing same |
US4560548A (en) * | 1984-04-10 | 1985-12-24 | The Dow Chemical Company | Bone seeking Tc-99m complexes of phosphonate derivatives of bis(aminoalkyl)piperazine |
US4882142A (en) * | 1988-12-19 | 1989-11-21 | The Dow Chemical Company | Bone marrow suppressing agents |
US5192526A (en) * | 1989-05-02 | 1993-03-09 | Mallinckrodt Medical, Inc. | Kit for preparation of rhenium therapeutic agents for bone cancer without purification |
LU87684A1 (de) * | 1990-02-23 | 1991-10-08 | Euratom | Verfahren zur erzeugung von aktinium-225 und wismut-213 |
US5902825A (en) * | 1997-01-07 | 1999-05-11 | Mitreoak, Ltd. | Composition and method for the palliation of pain associated with diseases of the bone and bone joints |
FI104901B (fi) * | 1997-10-20 | 2000-04-28 | Leiras Oy | Uudet metyleenibisfosfonihappojohdannaiset |
NO310544B1 (no) | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
JP2003501488A (ja) * | 1999-06-11 | 2003-01-14 | ネオルックス コーポレイション | 骨髄抑制のための高投与量放射性核種錯体 |
NO314537B1 (no) | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
NO312708B1 (no) | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
CA2381123C (en) | 2000-02-25 | 2011-10-04 | Dangshe Ma | Actinium-225 complexes and conjugates for radioimmunotherapy |
NO313180B1 (no) | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
US6548042B2 (en) * | 2000-08-07 | 2003-04-15 | Arstad Erik | Bis-phosphonate compounds |
US6670456B2 (en) * | 2001-02-28 | 2003-12-30 | Dow Global Technologies Inc. | Actinium-225 complexes and conjugates for targeted radiotherapy |
GB0213261D0 (en) | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
US20030086868A1 (en) * | 2002-08-12 | 2003-05-08 | Dangshe Ma | Actinium-225 complexes and conjugates for radioimmunotherapy |
GB0308731D0 (en) | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
US20060228297A1 (en) | 2003-04-15 | 2006-10-12 | Roy Larsen | Thorium-227 for use in radiotherapy of soft tissue disease |
-
2000
- 2000-07-04 NO NO20003457A patent/NO313180B1/no not_active IP Right Cessation
-
2001
- 2001-07-04 KR KR1020037000060A patent/KR100892002B1/ko not_active IP Right Cessation
- 2001-07-04 ES ES01945519T patent/ES2250419T3/es not_active Expired - Lifetime
- 2001-07-04 DE DE60113683T patent/DE60113683T2/de not_active Expired - Lifetime
- 2001-07-04 AT AT01945519T patent/ATE305313T1/de active
- 2001-07-04 JP JP2002511790A patent/JP5219325B2/ja not_active Expired - Fee Related
- 2001-07-04 EP EP01945519A patent/EP1296722B1/en not_active Expired - Lifetime
- 2001-07-04 EA EA200201258A patent/EA004899B1/ru not_active IP Right Cessation
- 2001-07-04 CZ CZ20030334A patent/CZ299087B6/cs not_active IP Right Cessation
- 2001-07-04 US US10/332,056 patent/US7056275B2/en not_active Expired - Fee Related
- 2001-07-04 DK DK01945519T patent/DK1296722T3/da active
- 2001-07-04 CA CA002413736A patent/CA2413736C/en not_active Expired - Fee Related
- 2001-07-04 WO PCT/GB2001/002996 patent/WO2002005859A2/en active IP Right Grant
- 2001-07-04 AU AU2001267734A patent/AU2001267734B2/en not_active Ceased
- 2001-07-04 AU AU6773401A patent/AU6773401A/xx active Pending
- 2001-07-04 PL PL366070A patent/PL206209B1/pl unknown
-
2006
- 2006-01-23 US US11/337,385 patent/US7335154B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60113683D1 (en) | 2006-02-09 |
WO2002005859A3 (en) | 2002-09-06 |
US20060135842A1 (en) | 2006-06-22 |
US7056275B2 (en) | 2006-06-06 |
KR100892002B1 (ko) | 2009-04-07 |
JP5219325B2 (ja) | 2013-06-26 |
CA2413736A1 (en) | 2002-01-24 |
AU6773401A (en) | 2002-01-30 |
PL366070A1 (en) | 2005-01-24 |
WO2002005859A2 (en) | 2002-01-24 |
NO20003457L (no) | 2002-01-07 |
AU2001267734B2 (en) | 2005-09-01 |
CZ299087B6 (cs) | 2008-04-23 |
KR20030029100A (ko) | 2003-04-11 |
ATE305313T1 (de) | 2005-10-15 |
EA004899B1 (ru) | 2004-08-26 |
NO20003457D0 (no) | 2000-07-04 |
EP1296722A2 (en) | 2003-04-02 |
ES2250419T3 (es) | 2006-04-16 |
JP2004503331A (ja) | 2004-02-05 |
US20030166989A1 (en) | 2003-09-04 |
US7335154B2 (en) | 2008-02-26 |
EP1296722B1 (en) | 2005-09-28 |
CA2413736C (en) | 2009-08-18 |
NO313180B1 (no) | 2002-08-26 |
PL206209B1 (pl) | 2010-07-30 |
DE60113683T2 (de) | 2006-07-06 |
EA200201258A1 (ru) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE305313T1 (de) | Radiotherapy | |
CY1121113T1 (el) | Θεραπεια της νοσου ρομρε | |
CY1110256T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
EA200100642A1 (ru) | Получение и применение радия-223 для направленной доставки к кальцифицированным тканям в целях временного ослабления боли, терапии рака кости и кондиционирования костной поверхности | |
SI1472541T1 (sl) | Prikazovalni agensi in postopek prikazovanja naaladase ali psma | |
CY1115407T1 (el) | Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων | |
WO2003105757A3 (en) | METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET | |
DE60225702D1 (de) | Strontium verbindung zur behandlung von sub-dermalem weichteilschmerz | |
ATE523224T1 (de) | Verifizierung von läsionsmerkmalen mit strahlformen | |
ATE262909T1 (de) | Intravenöse alendronatformulierungen | |
SI1750596T1 (sl) | Povezovalni element ki ga je moč vstaviti v notranjost kostne strukture človeškega ali živalskega telesa in pripadajoč sistem za lociranje | |
BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
Levendag et al. | A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx | |
TR200101693T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
CY1111522T1 (el) | 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο | |
AR031641A1 (es) | Combinacion inmunoterapeutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina | |
BR112022026094A2 (pt) | Usos de um inibidor de hif-2a e lenvatinibe, ou um sal farmaceuticamente aceitável do mesmo, e de uma combinação terapêutica, e, kit | |
PL367707A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
NO20064232L (no) | Alfa.emitterende hydroksyapatittparikler | |
MXPA05006722A (es) | Metodo para tratamiento de pacientes con exposicion a radiacion. | |
AU2002319223A1 (en) | Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein | |
Iwamoto et al. | Radiation therapy for prostate cancer | |
DE502004012439D1 (de) | Medikament und verwendung zur tumortherapie | |
UA11383U (uk) | Спосіб терапії хворих на рак щитовидної залози з множинними метастазами в скелет | |
GT199600036A (es) | Vacunacion in ovo contra la coccidiosis. |